New therapeutic approach for prurigo nodularis

- EN - DE
Dermatologist Jörg Wenzel - of University Hospital Bonn and University of Bonn.
Dermatologist Jörg Wenzel - of University Hospital Bonn and University of Bonn. © Foto: UKB/Alessandro Winkler all images in original size .
Dermatologist Prof. Jörg Wenzel of Bonn University Hospital and University of Bonn has collaborated with Incyte, a U.S.-based global biopharmaceutical company, to develop a strategy for treating patients with severe pruritus (prurigo nodularis) with ruxolitinib cream. The University of Bonn and Incyte have now entered into an agreement whereby Incyte has acquired the rights to a related joint patent application from Bonn.

"Chronic itching is a common and very distressing condition in our patient population," says Jörg Wenzel, co-inventor and senior physician at the Centre for Skin Diseases at the UKB. ...
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.

Register


Login


Subscribe